Bepo

Approaches for Systemic Delivery of Dystrophin Antisense Peptide Nucleic Acid in the mdx Mouse Model

By MedincellJune 4, 2021March 5th, 2024No Comments

Approaches for Systemic Delivery of Dystrophin Antisense Peptide Nucleic Acid in the mdx Mouse Model

June 4, 2021

Previous PostImpact of octreotide counterion nature on the long-term stability and release kinetics from an in situ forming depot technology
Next PostPoly(ethylene glycol)-b-poly(1,3-trimethylene carbonate) Copolymers for the Formulation of In Situ Forming Depot Long-Acting Injectables

Better medicine for all

Website by ScreenUp